Archford Capital Strategies, LLC Gilead Sciences, Inc. Transaction History

Archford Capital Strategies, LLC

$681 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$73.94 - $80.67 $8,281 - $9,035	112 Added 1.41%	8,030 $601,000
Q2 2023 Aug 02, 2023	SELL	$76.01 - $86.7 $18,546 - $21,154	-244 Reduced 2.99%	7,918 $610,000
Q1 2023 Apr 18, 2023	BUY	$77.31 - $88.08 $11,209 - $12,771	145 Added 1.81%	8,162 $677,000
Q4 2022 Jan 26, 2023	BUY	$62.32 - $89.47 $41,754 - $59,944	670 Added 9.12%	8,017 $0
Q3 2022 Oct 17, 2022	BUY	$59.54 - $68.01 $10,895 - $12,445	183 Added 2.55%	7,347 $453,000
Q2 2022 Jul 12, 2022	BUY	$57.72 - $65.01 $113,997 - $128,394	1,975 Added 38.06%	7,164 $443,000
Q1 2022 Apr 18, 2022	BUY	$57.92 - $72.58 $17,028 - $21,338	294 Added 6.01%	5,189 $310,000
Q4 2021 Jan 20, 2022	BUY	$64.88 - $73.64 $14,468 - $16,421	223 Added 4.77%	4,895 $355,000
Q3 2021 Oct 14, 2021	BUY	$67.69 - $73.03 $19,765 - $21,324	292 Added 6.67%	4,672 $326,000
Q2 2021 Jul 23, 2021	BUY	$63.47 - $69.35 $27,228 - $29,751	429 Added 10.86%	4,380 $302,000
Q1 2021 Apr 26, 2021	SELL	$60.0 - $68.46 $400,260 - $456,696	-6,671 Reduced 62.8%	3,951 $260,000
Q4 2020 Jan 19, 2021	BUY	$56.65 - $64.55 $15,408 - $17,557	272 Added 2.63%	10,622 $670,000
Q3 2020 Oct 19, 2020	BUY	$62.1 - $78.08 $27,199 - $34,199	438 Added 4.42%	10,350 $654,000
Q2 2020 Jul 24, 2020	BUY	$72.34 - $84.0 $10,778 - $12,516	149 Added 1.53%	9,912 $763,000
Q1 2020 Apr 29, 2020	BUY	$62.63 - $80.22 $611,456 - $783,187	9,763 New	9,763 $730,000
Q3 2019 Oct 23, 2019	SELL	$62.51 - $69.0 $81,263 - $89,700	-1,300 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $10,594 - $13,825	-175 Reduced 11.86%	1,300 $81,000
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $107,439 - $130,980	1,475 New	1,475 $106,000
Q4 2017 Feb 16, 2018	SELL	$71.15 - $83.52 $293,493 - $344,520	-4,125 Closed	0 $0
Q3 2017 Nov 17, 2017	BUY	$72.11 - $85.47 $292,045 - $346,153	4,050 Added 5400.0%	4,125 $334,000
Q2 2017 Aug 18, 2017	BUY	N/A	75	75 $3,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archford Capital Strategies, LLC with notifications on news.

Account